A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML |
Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Discovery of New Targets and Pathways for T-ALL Therapy |
Dana-Farber Cancer Institute / Thomas Look |
Bridge Grants |
2012 |
Massachusetts |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |
Regulation of Hematopoietic Stem Cell Engraftment by the Endothelial Cell Niche |
Boston Children’s Hospital / Bradley Blaser, MD, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Targeted Therapy for Core Binding Factor Leukemia |
University of Massachusetts Medical School / John Pulikkan, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Barcoding Pediatric Leukemia for Therapeutic Purposes |
Boston Children’s Hospital / Leonard Zon, MD |
Crazy 8 Awards |
2020 |
Massachusetts |
Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21 |
Dana-Farber Cancer Institute / Andrew Lane, MD, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
The Therapy-Related Symptom Checklist for Children (TRSC-C): Systematic Monitoring of Symptoms to Improve Oncology Interventions.
|
Kansas Medical Center Research Institute, Inc. / Phoebe Williams |
Nurse Researcher Grants |
2008 |
Kansas |
Childhood Leukemia in Kenya Identified Through Malaria Slide Review |
Indiana University / Terry Vik |
Epidemiology Grants |
2012 |
Indiana |